Sale!

KAT6A Gene Mental Retardation Autosomal Dominant Type 32 Genetic Test

4,400 د.إ

-21%

The KAT6A Gene Mental Retardation Autosomal Dominant Type 32 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the KAT6A gene that are associated with Autosomal Dominant Mental Retardation Type 32. This condition is characterized by intellectual disability and possibly other neurological or physical abnormalities, resulting from genetic variations that affect normal brain development and function. The test, priced at 4400 AED, involves analyzing the patient’s DNA to detect specific genetic alterations in the KAT6A gene that are known to cause this disorder. By identifying these mutations, the test provides essential information for accurate diagnosis, which is crucial for management, treatment planning, and genetic counseling for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KAT6A Gene Mental Retardation Autosomal Dominant Type 32 Genetic Test

Welcome to DNA Labs UAE, your trusted genetic lab in UAE. In this blog, we will discuss the KAT6A Gene Mental Retardation Autosomal Dominant Type 32 Genetic Test, including its cost, symptoms, diagnosis, and other important details.

Test Name: KAT6A Gene Mental Retardation Autosomal Dominant Type 32 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for KAT6A Gene Mental retardation, autosomal dominant type 32 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KAT6A Gene Mental retardation, autosomal dominant type 32.

Test Details

The KAT6A gene is associated with a condition called mental retardation, autosomal dominant type 32 (MRD32). This condition is characterized by intellectual disability, developmental delay, and other neurological abnormalities.

NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of MRD32, NGS genetic testing can be used to identify any mutations or variations in the KAT6A gene that may be causing the condition. By identifying the specific genetic mutation or variation in the KAT6A gene, NGS genetic testing can provide a definitive diagnosis for individuals suspected of having MRD32. This can help guide medical management, provide information on recurrence risks, and offer genetic counseling to affected individuals and their families.

Thank you for reading our blog on the KAT6A Gene Mental Retardation Autosomal Dominant Type 32 Genetic Test. If you have any further questions or would like to schedule a test, please contact our Genetics Test Department or consult with a Neurologist.

Test Name KAT6A Gene Mental retardation autosomal dominant type 32 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KAT6A Gene Mental retardation, autosomal dominant type 32 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KAT6A Gene Mental retardation, autosomal dominant type 32
Test Details

The KAT6A gene is associated with a condition called mental retardation, autosomal dominant type 32 (MRD32). This condition is characterized by intellectual disability, developmental delay, and other neurological abnormalities.

NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of MRD32, NGS genetic testing can be used to identify any mutations or variations in the KAT6A gene that may be causing the condition.

By identifying the specific genetic mutation or variation in the KAT6A gene, NGS genetic testing can provide a definitive diagnosis for individuals suspected of having MRD32. This can help guide medical management, provide information on recurrence risks, and offer genetic counseling to affected individuals and their families.